Eisai launches LEQEMBI for early Alzheimer’s disease treatment in India
Eisai has launched LEQEMBI (lecanemab) in India after receiving CDSCO approval, introducing the country’s first disease-modifying therapy for early Alzheimer’s…
Eisai has launched LEQEMBI (lecanemab) in India after receiving CDSCO approval, introducing the country’s first disease-modifying therapy for early Alzheimer’s…